Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells (original) (raw)
Cytokine-driven regulation of NK cell functions in tumor immunity: Role of the MICA-NKG2D system
Carolina Domaica
Cytokine & Growth Factor Reviews, 2007
View PDFchevron_right
Tumor-derived soluble MICs impair CD3+CD56+ NKT-like cell cytotoxicity in cancer patients
Di Yang
Immunology Letters, 2008
View PDFchevron_right
NKG2D-independent suppression of T cell proliferation by H60 and MICA
Matthias Schiemann
Proceedings of the National Academy of Sciences, 2005
View PDFchevron_right
Endothelial Cell Activation and Proliferation Modulate NKG2D Activity by Regulating MICA Expression and Shedding
Béatrice Charreau, Anca Cimpean
Journal of Innate Immunity, 2014
View PDFchevron_right
Intracellular Expression of MICA in Activated CD4 T Lymphocytes and Protection from NK Cell-Mediated MICA-Dependent Cytotoxicity
Luciana Molinero
Human immunology, 2006
View PDFchevron_right
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Charles Yoon
Science (New York, N.Y.), 2018
View PDFchevron_right
The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA
pranali shah
Immunogenetics, 2015
View PDFchevron_right
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
Michael Girardi, Adrian Hayday
Nature Immunology, 2005
View PDFchevron_right
Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
Jeremy N Skepper
Cancer Research, 2010
View PDFchevron_right
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA
Petra Stieber
Cancer Immunology, Immunotherapy, 2006
View PDFchevron_right
Faculty of 1000 evaluation for Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Benoit Van den Eynde
F1000 - Post-publication peer review of the biomedical literature, 2018
View PDFchevron_right
Intracellular Retention of the NKG2D Ligand MHC Class I Chain-Related Gene A in Human Melanomas Confers Immune Privilege and Prevents NK Cell-Mediated Cytotoxicity
Carito Domaica
The Journal of Immunology, 2008
View PDFchevron_right
MICA/NKG2D-mediated immunogene therapy of experimental gliomas
Hans-jörg Bühring
Cancer research, 2003
View PDFchevron_right
Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated …
Luciana Molinero
The Journal of …, 2008
View PDFchevron_right
Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding
Catharina Gross, Mar Valés-gómez
European Journal of Immunology, 2011
View PDFchevron_right
Epithelial-Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
Luis Rodrigo
The Journal of Immunology, 2013
View PDFchevron_right
Broad tumor-associated expression and recognition by tumor-derived T cells of MICA and MICB
H. Secrist, Veronika Groh
Proceedings of the National Academy of Sciences, 1999
View PDFchevron_right
Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells
Andrea Benitez
Oncogene, 2013
View PDFchevron_right
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
Paola Rivera
European Journal of Immunology, 2001
View PDFchevron_right
Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in …
Luis F Jave-Suarez
BMC …, 2008
View PDFchevron_right
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
Alejandro Bravo Cuellar
BMC Immunology, 2012
View PDFchevron_right
Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions
Adriana Aguilar
BMC Cancer, 2008
View PDFchevron_right
Role of NKG2D In Tumor Cell Lysis Mediated by Human NK Cells: Cooperation With Natural Cytotoxicity Receptors and Capability of Recognizing Tumors of Nonepithelial …
Paola lizeth Zelaya rivera
European Journal …, 2001
View PDFchevron_right